Nutritional genomics: The next frontier in the postgenomic era

Physiological Genomics

Volumn 16, Issue , 2004, Pages 166-177

  Kaput, Jim ^a   Rodriguez, Raymond L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diet; Diet regulated genes; Gene expression; Nutrition

Indexed keywords

CHRONIC DISEASE; DIET; DIETARY INTAKE; DISEASE SEVERITY; GENE CONTROL; GENE EXPRESSION REGULATION; GENE STRUCTURE; GENETIC ANALYSIS; GENOMICS; HEALTH CARE; HEALTH HAZARD; NUTRITIONAL SCIENCE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HUMAN; NUTRITION;

CHRONIC DISEASE; DIET; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; HUMANS; NUTRITION PHYSIOLOGY; RISK FACTORS; VARIATION (GENETICS);

EID: 1842483155     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00107.2003     Document Type: Review

References (173)

1. Ames BN and Gold LS. The causes and prevention of cancer: gaining perspective. Environ Health Perspect 105, Suppl 4: 865-873, 1997.
2. Ames BN. Micronutrients prevent cancer and delay aging. Toxicol Lett 102-103: 5-18, 1998.
3. Ames BN and Gold LS. The causes and prevention of cancer: the role of environment. Biotherapy 11: 205-220, 1998.
4. Ames BN and Gold LS. Paracelsus to parascience: the environmental cancer distraction. Mutat Res 447: 3-13, 2000.
5. Ames BN. DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res 475: 7-20, 2001.
6. m): relevance to genetic disease and polymorphisms. Am J Clin Nutr 75: 616-658, 2002.
7. Ames BN and Wakimoto P. Are vitamin and mineral deficiencies a major cancer risk? Nat Rev Cancer 2: 694-704, 2002.
8. Augustin LS, Franceschi S, Jenkins DJ, Kendall CW, and La Vecchia C. Glycemic index in chronic disease: a review. Eur J Clin Nutr 56: 1049-1071, 2002.
9. Auwerx J. Regulation of gene expression by fatty acids and fibric acid derivatives: an integrative role for peroxisome proliferator activated receptors. The Belgian Endocrine Society Lecture 1992. Horm Res 38: 269-277, 1992.
10. Bairati I, Meyer F, Fradet Y, and Moore L. Dietary fat and advanced prostate cancer. J Urol 159: 1271-1275, 1998.
11. Benbow U, Tower GB, Wyatt CA, Buttice G, and Brinckerhoff CE. High levels of MMP-1 expression in the absence of the 2G single nucleotide polymorphism is mediated by p38 and ERK1/2 mitogen-activated protein kinases in VMM5 melanoma cells. J Cell Biochem 86: 307-319, 2002.
12. Bingham S. Meat, starch and non-starch polysaccharides, are epidemiological and experimental findings consistent with acquired genetic alterations in sporadic colorectal cancer? Cancer Lett 114: 25-34, 1997.
13. Black SA. Diabetes, diversity, and disparity: what do we do with the evidence? Am J Public Health 92: 543-548, 2002.
14. Blount BC, Mack MM, Wehr CM, Macgregor JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB, and Ames BN. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 94: 3290-3295, 1997.
15. Boden G. Pathogenesis of type 2 diabetes. Insulin resistance. Endocrinol Metab Clin North Am 30: 801-815, 2001.
16. Bream JH, Ping A, Zhang X, Winkler C, and Young HA. A single nucleotide polymorphism in the proximal IFN-gamma promoter alters control of gene transcription. Genes Immun 3: 165-169, 2002.
17. Cao SX, Dhahbi JM, Mote PL, and Spindler SR. Genomic profiling of short- and long-term caloric restriction effects in the liver of aging mice. Proc Natl Acad Sci USA 98: 10630-10635, 2001.
18. Cardon LR and Bell JL. Association study designs for complex diseases. Nat Rev Genet 2: 91-99, 2001.
19. Chawla A, Repa JJ, Evans RM, and Mangelsdorf DJ. Nuclear receptors and lipid physiology: opening the X-files. Science 294: 1866-1870, 2001.
20. Chen J, Giovannucci EL, and Hunter DJ. Mthfr polymorphism, methyl-replete diets and the risk of colorectal carcinoma and adenoma among US men and women: an example of gene-environment interactions in colorectal tumorigenesis. J Nutr 129: 560S-564S, 1999.
21. Clarke SD and Abraham S. Gene expression: nutrient control of pre- and posttranscriptional events. FASEB J 6: 3146-3152, 1992.
22. Clarke SD. Nutrient regulation of gene and protein expression. Curr Opin Clin Nutr Metab Care 2: 287-289, 1999.
23. Clinton SK, Bostwick DG, Olson LM, Mangian HJ, and Visek WJ. Effects of ammonium acetate and sodium cholate on N-methyl-N′ -nitro-N-nitrosoguanidine-induced colon carcinogenesis of rats. Cancer Res 48: 3035-3039, 1988.
24. Collins FS, Guyer MS, and Charkravarti A. Variations on a theme: cataloging human DNA sequence variation. Science 278: 1580-1581, 1997.
25. Collins-Schramm HE, Phillips CM, Operario DJ, Lee JS, Weber JL, Hanson RL, Knowler WC, Cooper R, Li H, and Seldin MF. Ethnic-difference markers for use in mapping by admixture linkage disequilibrium. Am J Hum Genet 70: 737-750, 2002.
26. Committee on Diet and Health Food and Nutrition Board, Commission on Life Sciences, National Research Council, Diet and Health. Implications for Reducing Chronic Disease Risk. Washington, DC: National Academy Press, 1989.
27. Cooney CA, Dave AA, and Wolff GL. Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J Nutr 132: 2393S-2400S, 2002.
28. Cortessis V, Siegmund K, Chen Q, Zhou N, Diep A, Frankl H, Lee E, Zhu QS, Haile R, and Levy D. A case-control study of microsomal epoxide hydrolase, smoking, meat consumption, glutathione S-transferase M3, and risk of colorectal adenomas. Cancer Res 61: 2381-2385, 2001.
29. Cousins RJ. Nutritional regulation of gene expression. Am J Med 106: 20S-23S, 50S-51S, 1999.
30. Da Silva P, Aitken RP, Rhind SM, Racey PA, and Wallace JM. Impact of maternal nutrition during pregnancy on pituitary gonadotrophin gene expression and ovarian development in growth-restricted and normally grown late gestation sheep fetuses. Reproduction 123: 769-777, 2002.
31. Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, and Lander ES. High-resolution haplotype structure in the human genome. Nat Genet 29: 229-232, 2001.
32. Dauncey MJ, White P, Burton KA, and Katsumata M. Nutrition-hormone receptor-gene interactions: implications for development and disease. Proc Nutr Soc 60: 63-72, 2001.
33. De Caterina R, Madonna R, Hassan J, and Procopio AD. Nutrients and gene expression. World Rev Nutr Diet 89: 23-52, 2001.
34. Deng HW, Chen WM, and Recker RR. Population admixture: detection by Hardy-Weinberg test and its quantitative effects on linkage-disequilibrium methods for localizing genes underlying complex traits. Genetics 157: 885-897, 2001.
35. Despres JP. Health consequences of visceral obesity. Ann Med 33: 534-541, 2001.
36. Dhahbi JM, Mote PL, Wingo J, Tillman JB, Walford RL, and Spindler SR. Calories and aging alter gene expression for gluconeogenic, glycolytic, and nitrogen-metabolizing enzymes. Am J Physiol Endocrinol Metab 277: E352-E360, 1999.
37. Dong Z, Huang C, and Ma WY. PI-3 kinase in signal transduction, cell transformation, and as a target for chemoprevention of cancer. Anticancer Res 19: 3743-3747, 1999.
38. Dong Z. Effects of food factors on signal transduction pathways. Biofactors 12: 17-28, 2000.
39. Douglas JA, Erdos MR, Watanabe RM, Braun A, Johnston CL, Oeth P, Mohlke KL, Valle TT, Ehnholm C, Buchanan TA, Bergman RN, Collins FS, Boehnke M, and Tuomilehto J. The peroxisome proliferator-activated receptor-gamma2 Pro12A1a a variant: association with type 2 diabetes and trait differences. Diabetes 50: 886-890, 2001.
40. Dreon DM, Fernstrom HA, Williams PT, and Krauss RM. A very-low-fat diet is not associated with improved lipoprotein profiles in men with a predominance of large, low-density lipoproteins. Am J Clin Nutr 69: 411-418, 1999.
41. Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, and Wahli W. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68: 879-887, 1992.
42. Eastwood MA. A molecular biological basis for the nutritional and pharmacological benefits of dietary plants. QJM 94: 45-48, 2001.
43. Eberharter A and Becker PB. Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep 3: 224-229, 2002.
44. Edwards PA, Tabor D, Kast HR, and Venkateswaran A. Regulation of gene expression by SREBP and SCAP. Biochim Biophys Acta 1529: 103-113, 2000.
45. Ekins S, Mirny L, and Schuetz EG. A ligand-based approach to understanding selectivity of nuclear hormone receptors PXR, CAR, FXR, LXRalpha, and LXRbeta. Pharm Res 19: 1788-1800, 2002.
46. Elson-Schwab I, Poedjosoedarmo K, and Ames BN. KmMutants.org [Online]. Children's Hospital Oakland Research Institute. http://www. kmmutants.org (updated 19 August 2002).
47. Enattah NS, Sahi T, Savilahti E, Terwilliger JD, Peltonen L, and Jarvela I. Identification of a variant associated with adult-type hypolactasia. Nat Genet 30: 233-237, 2002.
48. Ernst ND, Sempos CT, Briefel RR, and Clark MB. Consistency between US dietary fat intake and serum total cholesterol concentrations: the National Health and Nutrition Examination Surveys. Am J Clin Nutr 66: 965S-972S, 1997.
49. Fafournoux P, Bruhat A, and Jousse C. Amino acid regulation of gene expression. Biochem J 351: 1-12, 2000.
50. Fairfield KM and Fletcher RH. Vitamins for chronic disease prevention in adults: scientific review. JAMA 287: 3116-3126, 2002.
51. Falk E, Zhou J, and Moller J. Homocysteine and atherothrombosis. Lipids 36, Suppl: S3-S11, 2001.
52. Felipo V and Butterworth RF. Neurobiology of ammonia. Prog Neurobiol 67: 259-279, 2002.
53. Figura N. Helicobacter pylori factors involved in the development of gastroduodenal mucosal damage and ulceration. J Clin Gastroenterol 25, Suppl 1: S149-S163, 1997.
54. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, and Evans RM. 15-Deoxy-delta 12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83: 803-812, 1995.
55. Francis GA, Fayard E, Picard F, and Auwerx J. Nuclear receptors and the control of metabolism. Annu Rev Physiol 65: 261-311, 2003.
56. Frankel WN. Taking stock of complex trait genetics in mice. Trends Genet 11: 471-477, 1995.
57. Freedman AN, Michalek AM, Marshall JR, Mettlin CJ, Petrelli NJ, Black JD, Zhang ZF, Satchidanand S, and Asirwatham JE. Familial and nutritional risk factors for p53 overexpression in colorectal cancer. Cancer Epidemiol Biomarkers Prev 5: 285-291, 1996.
58. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, and Altshuler D. The structure of haplotype blocks in the human genome. Science 296: 2225-2229, 2002.
59. Gasser SM and Cockell MM. The molecular biology of the SIR proteins. Gene 279: 1-16, 2001.
60. Gatof D and Ahnen D. Primary prevention of colorectal cancer: diet and drugs. Gastroenterol Clin North Am 31: 587-623, xi, 2002.
61. Goodridge AG. Dietary regulation of gene expression: enzymes involved in carbohydrate and lipid metabolism. Annu Rev Nutr 7: 157-185, 1987.
62. Goodridge AG. The role of nutrients in gene expression. World Rev Nutr Diet 63: 183-193, 1990.
63. Gottlicher M, Widmark E, Li Q, and Gustafsson JA. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc Natl Acad Sci USA 89: 4653-4657, 1992.
64. Hietanen E, Husgafvel-Pursiainen K, and Vainio H. Interaction between dose and susceptibility to environmental cancer: a short review. Environ Health Perspect 105, Suppl 4: 749-754, 1997.
65. Hirschhorn JN, Lohmueller K, Byrne E, and Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 4: 45-61, 2002.
66. Hirschi KD, Kreps JA, and Hirschi KK. Molecular approaches to studying nutrient metabolism and function: an array of possibilities. J Nutr 131: 1605S-1609S, 2001.
67. Hollox EJ, Poulter M, Wang Y, Krause A, and Swallow DM. Common polymorphism in a highly variable region upstream of the human lactase gene affects DNA-protein interactions. Eur J Hum Genet 7: 791-800, 1999.
68. Huang Z, Bodkin NL, Ortmeyer HK, Zenilman ME, Webster NJ, Hansen BC, and Shuldiner AR. Altered insulin receptor messenger ribonucleic acid splicing in liver is associated with deterioration of glucose tolerance in the spontaneously obese and diabetic rhesus monkey: analysis of controversy between monkey and human studies. J Clin Endocrinol Metab 81: 1552-1556, 1996.
69. Jackson AA. Nutrients, growth, and the development of programmed metabolic function. Adv Exp Med Biol 478: 41-55, 2000.
70. Jacobs MN and Lewis DF. Steroid hormone receptors and dietary ligands: a selected review. Proc Nutr Soc 61: 105-122, 2002.
71. James RW. Diabetes and other coronary heart disease risk equivalents. Curr Opin Lipidol 12: 425-431, 2001.
72. Jenkins D, Wolever TMS, Taylor RH, Barker H, Fielden H, Baldwin JM, Bowling AC, Newman HC, Jenkins AL, and Goff DV. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr 34: 1981.
73. Jenkins DJ, Kendall CW, Augustin LS, Franceschi S, Hamidi M, Marchie A, Jenkins AL, and Axelsen M. Glycemic index: overview of implications in health and disease. Am J Clin Nutr 76: 266S-273S, 2002.
74. Jenkins DJA, Kendall CCW, and Ransom TPP. Dietary fiber, the evolution of the human diet and coronary heart disease. Nutr Res 18: 633-652, 1998.
75. Jimenez-Sanchez G, Childs B, and Valle D. Human disease genes. Nature 409: 853-855, 2001.
76. Johnson GC, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G, Ueda H, Cordell HJ, Eaves IA, Dudbridge F, Twells RC, Payne F, Hughes W, Nutland S, Stevens H, Carr P, Tuomilehto-Wolf E, Tuomilehto J, Gough SC, Clayton DG, and Todd JA. Haplotype tagging for the identification of common disease genes. Nat Genet 29: 233-237, 2001.
77. Judson R, Salisbury B, Schneider J, Windemuth A, and Stephens JC. How many SNPs does a genome-wide haplotype map require? Pharmacogenomics 3: 379-391, 2002.
78. Kant AK. Consumption of energy-dense, nutrient-poor foods by adult Americans: nutritional and health implications. The Third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 72: 929-936, 2000.
79. Kaput J, Swartz D, Paisley E, Mangian H, Daniel WL, and Visek WJ. Diet-disease interactions at the molecular level: an experimental paradigm. J Nutr 124: 1296S-1305S, 1994.
80. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, and Lehmann JM. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83: 813-819, 1995.
81. Kliewer SA, Xu HE, Lambert MH, and Willson TM. Peroxisome proliferator-activated receptors: from genes to physiology. Recent Prog Horm Res 56: 239-263, 2001.
82. Kolonel LN. Fat, meat, and prostate cancer. Epidemiol Rev 23: 72-81, 2001.
83. Kostulas K, Crisby M, Huang WX, Lannfelt L, Hagenfeldt L, Eggertsen G, Kostulas V, and Hillert J. A methylenetetrahydrofolate reductase gene polymorphism in ischaemic stroke and in carotid artery stenosis. Eur J Clin Invest 28: 285-289, 1998.
84. Krauss RM. Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk. Curr Opin Lipidol 5: 339-349, 1994.
85. Krauss RM and Dreon DM. Low-density-lipoprotein subclasses and response to a low-fat diet in healthy men. Am J Clin Nutr 62: 478S-487S, 1995.
86. Krauss RM. Dietary and genetic effects on LDL heterogeneity. World Rev Nutr Diet 89: 12-22, 2001.
87. Krauss RM et al. (Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults). Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001.
88. Kuokkanen M, Enattah NS, Oksanen A, Savilahti E, Orpana A, and Jarvela I. Transcriptional regulation of the lactase-phlorizin hydrolase gene by polymorphisms associated with adult-type hypolactasia. Gut 52: 647-652, 2003.
89. Lamba JK, Lin YS, Schuetz EG, and Thummel KE. Genetic contribution to variable human CYP3A-mediated metabolism. Adv Drug Deliv Rev 54: 1271-1294, 2002.
90. Lander E and Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11: 241-247, 1995.
91. Lander ES. The new genomics: global views of biology. Science 274: 536-539, 1996.
92. Lander ES et al. (International Human Genome Sequencing Consortium). Initial sequencing and analysis of the human genome. Nature 409: 860-921, 2001.
93. Lee C, Atanelov L, Modrek B, and Xing Y. ASAP: the Alternative Splicing Annotation Project. Nucleic Acids Res 31: 101-105, 2003.
94. Lee CK, Klopp RG, Weindruch R, and Prolla TA. Gene expression profile of aging and its retardation by caloric restriction. Science 285: 1390-1393, 1999.
95. Lee CK, Allison DB, Brand J, Weindruch R, and Prolla TA. Transcriptional profiles associated with aging and middle age-onset caloric restriction in mouse hearts. Proc Natl Acad Sci USA 99: 14988-14993, 2002.
96. Lee MM and Lin SS. Dietary fat and breast cancer. Annu Rev Nutr 20: 221-248, 2000.
97. Lin SJ and Guarente L. Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease. Curr Opin Cell Biol 15: 241-246, 2003.
98. Linder CC. The influence of genetic background on spontaneous and genetically engineered mouse models of complex diseases. Lab Anim (NY) 30: 34-39, 2001.
99. Makridakis NM, di Salle E, and Reichardt JK. Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II. Pharmacogenetics 10: 407-413, 2000.
100. Masson LF, McNeill G, and Avenell A. Genetic variation and the lipid response to dietary intervention: a systematic review. Am J Clin Nutr 77: 1098-1111, 2003.
101. Masuda M, Suzui M, and Weinstein IB. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res 7: 4220-4229, 2001.
102. McCarthy JJ and Hilfiker R. The use of single-nucleotide polymorphism maps in pharmacogenomics. Nat Biotechnol 18: 505-508, 2000.
103. McKeigue PM, Carpenter JR, Parra EJ, and Shriver MD. Estimation of admixture and detection of linkage in admixed populations by a Bayesian approach: application to African-American populations. Ann Hum Genet 64: 171-186, 2000.
104. Moazed D. Enzymatic activities of Sir2 and chromatin silencing. Curr Opin Cell Biol 13: 232-238, 2001.
105. Morris SM Jr, Nilson JH, Jenik RA, Winberry LK, McDevitt MA, and Goodridge AG. Molecular cloning of gene sequences for avian fatty acid synthase and evidence for nutritional regulation of fatty acid synthase mRNA concentration. J Biol Chem 257: 3225-3229, 1982.
106. Mucci LA, Wedren S, Tamimi RM, Trichopoulos D, and Adami HO. The role of gene-environment interaction in the aetiology of human cancer: examples from cancers of the large bowel, lung and breast. J Intern Med 249: 477-493, 2001.
107. Muller M and Kersten S. Nutrigenomics: goals and strategies. Nat Rev Genet 4: 315-322, 2003.
108. Nathan DM. Clinical practice. Initial management of glycemia in type 2 diabetes mellitus. N Engl J Med 347: 1342-1349, 2002.
109. Nobel S, Abrahmsen L, and Oppermann U. Metabolic conversion as a pre-receptor control mechanism for lipophilic hormones. Eur J Biochem 268: 4113-4125, 2001.
110. Novelli G, Margiotti K, Sangiuolo F, and Reichardt JK. Pharmacogenetics of human androgens and prostatic diseases. Pharmacogenomics 2: 65-72, 2001.
111. Ordovas JM. HDL genetics: candidate genes, genome wide scans and gene-environment interactions. Cardiovasc Drugs Ther 16: 273-281, 2002.
112. Ordovas JM, Corella D, Cupples LA, Demissie S, Kelleher A, Coltell O, Wilson PW, Schaefer EJ, and Tucker K. Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: the Framingham Study. Am J Clin Nutr 75: 38-46, 2002.
113. Park EI, Paisley EA, Mangian HJ, Swartz DA, Wu MX, O'Morchoe PJ, Behr SR, Visek WJ, and Kaput J. Lipid level and type alter stearoyl CoA desaturase mRNA abundance differently in mice with distinct susceptibilities to diet-influenced diseases. J Nutr 127: 566-573, 1997.
114. Parra EJ, Marcini A, Akey J, Martinson J, Batzer MA, Cooper R, Forrester T, Allison DB, Deka R, Ferrell RE, and Shriver MD. Estimating African American admixture proportions by use of population-specific alleles. Am J Hum Genet 63: 1839-1851, 1998.
115. Patterson AH, Damon Hewitt S, JD, Zamir D, Rabinowitch HD, Lincoln SE, Lander ES, and Tanksley SD. Mendelian factors underlying quantitative traits in tomato: comparison across species, generations, and environments. Genetics 127: 181-197, 1991.
116. Perera FP and Weinstein IB. Molecular epidemiology: recent advances and future directions. Carcinogenesis 21: 517-524, 2000.
117. Perusse L and Bouchard C. Gene-diet interactions in obesity. Am J Clin Nutr 72: 1285S-1290S, 2000.
118. Pfaff CL, Parra EJ, Bonilla C, Hiester K, McKeigue PM, Kamboh MI, Hutchinson RG, Ferrell RE, Boerwinkle E, and Shriver MD. Population structure in admixed populations: effect of admixture dynamics on the pattern of linkage disequilibrium. Am J Hum Genet 68: 198-207, 2001.
119. Pianetti S, Guo S, Kavanagh KT, and Sonenshein GE. Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells. Cancer Res 62: 652-655, 2002.
120. Powell IJ and Meyskens FL Jr. African American men and hereditary/familial prostate cancer: intermediate-risk populations for chemoprevention trials. Urology 57: 178-181, 2001.
121. Prolla TA. DNA microarray analysis of the aging brain. Chem Senses 27: 299-306, 2002.
122. Reich DE and Goldstein DB. Detecting association in a case-control study while correcting for population stratification. Genet Epidemiol 20: 4-16, 2001.
123. Reichardt JK. GEN GEN: the genomic genetic analysis of androgen-metabolic genes and prostate cancer as a paradigm for the dissection of complex phenotypes. Front Biosci 4: D596-D600, 1999.
124. Reifsnyder PC, Churchill G, and Leiter EH. Maternal environment and genotype interact to establish diabesity in mice. Genome Res 10: 1568-1578, 2000.
125. Risch A, Wallace DM, Bathers S, and Sim E. Slow n-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum Mol Genet 4: 231-236, 1995.
126. Risch N, Ghosh S, and Todd JA. Statistical evaluation of multiple-locus linkage data in experimental species and its relevance to human studies: application to nonobese diabetic (NOD) mouse and human insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 53: 702-714, 1993.
127. Risch N. Evolving methods in genetic epidemiology. II. Genetic linkage from an epidemiologic perspective. Epidemiol Rev 19: 24-32, 1997.
128. Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, Sherry S, Mullikin JC, Mortimore BJ, Willey DL, Hunt SE, Cole CG, Coggill PC, Rice CM, Ning Z, Rogers J, Bentley DR, Kwok PY, Mardis ER, Yeh RT, Schultz B, Cook L, Davenport R, Dante M, Fulton L, Hillier L, Waterston RH, McPherson JD, Gilman B, Schaffner S, Van Etten WJ, Reich D, Higgins J, Daly MJ, Blumenstiel B, Baldwin J, Stange-Thomann N, Zody MC, Linton L, Lander ES, and Altshuler D. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409: 928-933, 2001.
129. Sachinidis A, Skach RA, Seul C, Ko Y, Hescheler J, Ahn HY, and Fingerle J. Inhibition of the PDGF beta-receptor tyrosine phosphorylation and its downstream intracellular signal transduction pathway in rat and human vascular smooth muscle cells by different catechins. FASEB J 16: 893-895, 2002.
130. Sachse C, Smith G, Wilkie MJ, Barrett JH, Waxman R, Sullivan F, Forman D, Bishop DT, and Wolf CR. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis 23: 1839-1849, 2002.
131. Salmeron JM, JE, Stampfer MJ, Colditz GA, Wing AL, and Willett WC. Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care 20: 545-550, 1997.
132. Schaefer EJ. Lipoproteins, nutrition, and heart disease. Am J Clin Nutr 75: 191-212, 2002.
133. Schmidt A, Endo N, Rutledge SJ, Vogel R, Shinar D, and Rodan GA. Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol Endocrinol 6: 1634-1641, 1992.
134. Schork NJ, Fallin D, and Lanchbury JS. Single nucleotide polymorphisms and the future of genetic epidemiology. Clin Genet 58: 250-264, 2000.
135. Shibata A and Whittemore AS. Genetic predisposition to prostate cancer: possible explanations for ethnic differences in risk. Prostate 32: 65-72, 1997.
136. Sing CF, Stengard JH, and Kardia SL. Genes, environment, and cardiovascular disease. Arterioscler Thromb Vasc Biol 23: 1190-1196, 2003.
137. Skibola CF, Smith MT, Kane E, Roman E, Rollinson S, Cartwright RA, and Morgan G. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 96: 12810-12815, 1999.
138. Slattery ML, Potter JD, Samowitz W, Schaffer D, and Leppert M. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 8: 513-518, 1999.
139. Smith-Warner SA, Spiegelman D, Adami HO, Beeson WL, van den Brandt PA, Folsom AR, Fraser GE, Freudenheim JL, Goldbohm RA, Graham S, Kushi LH, Miller AB, Rohan TE, Speizer FE, Toniolo P, Willett WC, Wolk A, Zeleniuch-Jacquotte A, and Hunter DJ. Types of dietary fat and breast cancer: a pooled analysis of cohort studies. Int J Cancer 92: 767-774, 2001.
140. Sniderman AD, Scantlebury T, and Cianflone K. Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus. Ann Intern Med 135: 447-459, 2001.
141. Song F, Srinivasan M, Aalinkeel R, and Patel MS. Use of a cDNA array for the identification of genes induced in islets of suckling rats by a high carbohydrate nutritional intervention. Diabetes 50: 2053-2060, 2001.
142. Spindler SR, Crew MD, Mote PL, Grizzle JM, and Walford RL. Dietary energy restriction in mice reduces hepatic expression of glucose-regulated protein 78 (BiP) and 94 mRNA. J Nutr 120: 1412-1417, 1990.
143. Stoehr JP, Nadler ST, Schueler KL, Rabaglia ME, Yandell BS, Metz SA, and Attie AD. Genetic obesity unmasks nonlinear interactions between murine type 2 diabetes susceptibility loci. Diabetes 49: 1946-1954, 2000.
144. Sugimoto K, Murakawa Y, Zhang W, Xu G, and Sima AA. Insulin receptor in rat peripheral nerve: its localization and alternatively spliced isoforms. Diabetes Metab Res Rev 16: 354-363, 2000.
145. Sunde RA. Research needs for human nutrition in the post-genome-sequencing era. J Nutr 131: 3319-3323, 2001.
146. Svetkey LP, Moore TJ, Simons-Morton DG, Appel LJ, Bray GA, Sacks FM, Ard JD, Mortensen RM, Mitchell SR, Conlin PR, and Kesari M. Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study. J Hypertens 19: 1949-1956, 2001.
147. Tabor HK, Risch NJ, and Myers RM. Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 3: 391-397, 2002.
148. Tishkoff SA and Williams SM. Genetic analysis of African populations: human evolution and complex disease. Nat Rev Genet 3: 611-621, 2002.
149. Turturro A, Blank K, Murasko D, and Hart R. Mechanisms of caloric restriction affecting aging and disease. Ann NY Acad Sci 719: 159-170, 1994.
150. Ulrich CM, Kampman E, Bigler J, Schwartz SM, Chen C, Bostick R, Fosdick L, Beresford SA, Yasui Y, and Potter JD. Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene-environment interaction? Cancer Epidemiol Biomarkers Prev 8: 659-668, 1999.
151. Ulrich CM, Bigler J, Whitton JA, Bostick R, Fosdick L, and Potter JD. Epoxide hydrolase Tyr113His polymorphism is associated with elevated risk of colorectal polyps in the presence of smoking and high meat intake. Cancer Epidemiol Biomarkers Prev 10: 875-882, 2001.
152. Uyeda K, Yamashita H, and Kawaguchi T. Carbohydrate responsive element-binding protein (ChREBP): a key regulator of glucose metabolism and fat storage. Biochem Pharmacol 63: 2075-2080, 2002.
153. van Dam RM, Willett WC, Rimm EB, Stampfer MJ, and Hu FB. Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care 25: 417-424, 2002.
154. Veierod MB, Laake P, and Thelle DS. Dietary fat intake and risk of prostate cancer: a prospective study of 25,708 Norwegian men. Int J Cancer 73: 634-638, 1997.
155. Velazquez A. Interactions between the genome and the environment, with special reference to nutrient variation. New concepts, emerging methodologies and challenges. World Rev Nutr Diet 89: 93-107, 2001.
156. Venter JC et al. (Celera Genomics). The sequence of the human genome. Science 291: 1304-1351, 2001.
157. Vincent S, Planells R, Defoort C, Bernard MC, Gerber M, Prudhomme J, Vague P, and Lairon D. Genetic polymorphisms and lipoprotein responses to diets. Proc Nutr Soc 61: 427-434, 2002.
158. Visek WJ. Effects of urea hydrolysis on cell life-span and metabolism. Fed Proc 31: 1178-1193, 1972.
159. Wade CM, Kulbokas EJ III, Kirby AW, Zody MC, Mullikin JC, Lander ES, Lindblad-Toh K, and Daly MJ. The mosaic structure of variation in the laboratory mouse genome. Nature 420: 574-578, 2002.
160. Wamberg S, Engel K, and Kildeberg P. Balance of net base in the rat. V. Effects of oral ammonium chloride loading. Biol Neonate 36: 99-108, 1979.
161. Watkins SM, Hammock BD, Newman JW, and German JB. Individual metabolism should guide agriculture toward foods for improved health and nutrition. Am J Clin Nutr 74: 283-286, 2001.
162. Weindruch R, Kayo T, Lee CK, and Prolla TA. Microarray profiling of gene expression in aging and its alteration by caloric restriction in mice. J Nutr 131: 918S-923S, 2001.
163. Weindruch R, Keenan KP, Carney JM, Fernandes G, Feuers RJ, Floyd RA, Halter JB, Ramsey JJ, Richardson A, Roth GS, and Spindler SR. Caloric restriction mimetics: metabolic interventions. J Gerontol A Biol Sci Med Sci 56: 20-33, 2001. (Spec No. 1)
164. Whorwood CB, Firth KM, Budge H, and Symonds ME. Maternal undernutrition during early to midgestation programs tissue-specific alterations in the expression of the glucocorticoid receptor, 11beta-hydroxysteroid dehydrogenase isoforms, and type 1 angiotensin II receptor in neonatal sheep. Endocrinology 142: 2854-2864, 2001.
165. Willett W. Isocaloric diets are of primary interest in experimental and epidemiological studies. Int J Epidemiol 31: 694-695, 2002.
166. Willett WC. Diet and breast cancer. J Intern Med 249: 395-411, 2001.
167. Willett WC. Balancing life-style and genomics research for disease prevention. Science 296: 695-698, 2002.
168. Witte KK, Clark AL, and Cleland JG. Chronic heart failure and micronutrients. J Am Coll Cardiol 37: 1765-1774, 2001.
169. Wolever TMS, Jenkins DJA, Jenkins AL, and Josse RG. The glycemic index: methodology and clinical implications. Am J Clin Nutr 54: 846-854, 1991.
170. Yan H, Yuan W, Velculescu VE, Vogelstein B, and Kinzler KW. Allelic variation in human gene expression. Science 297: 1143, 2002.
171. Ye SQ and Kwiterovich PO Jr. Influence of genetic polymorphisms on responsiveness to dietary fat and cholesterol. Am J Clin Nutr 72: 1275S-1284S, 2000.
172. Yoshino G, Hirano T, and Kazumi T. Atherogenic lipoproteins and diabetes mellitus. J Diabetes Complications 16: 29-34, 2002.
173. Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, and Ehm MG. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 53: 79-91, 2002.